PROject - Supportive and Palliative Care and INnOvation - Antwerp (Pro-Spinoza)

Implementation of the Care Pathway for Primary Palliative Care in Five Research Clusters in Belgium

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02266069

Acronym

pro-Spinoza

Enrollment

Registered

2014-10-16

Start date

2014-10-31

Completion date

2016-12-31

Last updated

2017-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Palliative Care, Primary Health Care

Keywords

implementation, anticipatory care planning, symptom assessment, interdisciplinary collaboration

Brief summary

It is important to provide high quality palliative care to all patients with a non-curable and life-limiting condition. The Care Pathway for Primary Palliative Care (CPPPC) provides tools for health care professionals to help them delivering palliative care timely and accurately.This study investigates whether the implementation of the CPPPC really helps to improve patients' lifes.

Interventions

OTHERCare Pathway for Primary Palliative Care

Early identification of palliative care patients, anticipatory care planning, systematic symptom assessment, interdisciplinary collaboration, rigorous follow-up of the functional status of the patient and giving attention to the informal care givers.

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

45 Years to No maximum

Healthy volunteers

Inclusion criteria

* identified as a palliative care patient using the Surprise Question Would you, as a family doctor, be surprised if this patient would die in the next 12 months?. If the answer is 'no', the patient is eligible for the study.

Exclusion criteria

* not having signed the informed consent.

Design outcomes

Primary

Measure	Time frame	Description
percentage of deaths occurred in the hospital (of patients per family doctor/per research cluster)	6 months	The hypothesis is that the CPPPC reduces the percentage of deaths occurred in the hospital

Secondary

Measure	Time frame	Description
cost of health care consumption in the last year of life (of patients per family doctor/per research cluster)	6 months	The hypothesis is that the CPPPC reduces the cost of health care consumption in the last year of life
consumption of antibiotics in the last year of life (of patients per family doctor/per research cluster)	6 months	The hypothesis is that the CPPPC reduces the consumption of antibiotics in the last year of life
consumption of pain killers in the last year of life (of patients per family doctor/per research cluster)	6 months	The hypothesis is that the CPPPC augments the consumption of pain killers in the last year of life
consumption of (invasive) diagnostic and therapeutic procedures in the last year of life (of patients per family doctor/per research cluster)	6 months	The hypothesis is that the CPPPC reduces the consumption of (invasive) diagnostic and therapeutic procedures in the last year of life

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 15, 2026